Pruritus clinical trials at UCSF
2 in progress, 1 open to eligible people
Pruritus is a type of itching. There is a study at UCSF for people with itching caused by primary biliary cholangitis. It will test if a new treatment is safe and works well. There is another study happening, but it is not taking new participants.
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
open to eligible people ages 18-80
This is a 2-part study in PBC participants with cholestatic pruritus and will evaluate the efficacy, safety and impact on health-related quality of life of linerixibat compared with placebo.
San Francisco, California and other locations
Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)
Sorry, not accepting new patients
An open-label, single-arm, multi-centre program providing treatment access to ALGS patients with cholestatic pruritus in the US. Access can be requested through Clinigen Healthcare Ltd via email MirumALGS@clinigengroup.com or telephone +1-877-768-4303.
San Francisco, California and other locations
Our lead scientists for Pruritus research studies include Monika Sarkar.
Last updated: